Introduction/Aim. Lentigo maligna (LM) represents an in situ melanoma that develops on chronically photo-damaged skin. Clinical diagnosis of LM is often difficult, even for experienced dermatologists. The aim of the study was to analyze the clinical and dermoscopic features of patients with pathohistologically verified lentigo maligna (LM) and to determine a possible influence of anatomical topography, age and gender in the dermoscopic features of LM. Patients and methods. This retrospective study included 32 patients with 32 LM changes in total, diagnosed between 2017 and 2020. Clinical data recorded from each patient included the following: demographic features (age, gender), anatomic localization (facial or extrafacial) and clinical size (< 10 mm or > 10 mm). Facial area was subdivided into eight topographical sites, while extrafacial localization involved any location outside the face region. All dermoscopic images were analyzed for the presence of dermoscopic features previously described as LM. Results. In the total of 32 patients, there were 19 males and 13 females. The patients' age ranged from 34 to 80 years (median age 60.1 ± 10.4 years). Significant female predominance was observed for localization on the cheeks (p = 0.018). Localization on the nose was significantly associated with patients older than 65 (p = 0.039). The most frequent dermoscopic features were asymmetric pigmented follicular openings in 23 (71.9%) cases, gray color in 22 (68.8%) and pigmented rhomboidal structures in 15 (46.9%) cases. In relation to age and specific dermoscopic features, gray color (p = 0.035) and white scar-like areas (p = 0.012) were significantly higher in patients older than 65, while pigmented rhomboidal structures (p = 0.041) were significantly associated with younger patients. Conclusion. The observed differences in the frequency of clinical and dermoscopic features of LM have significant importance in everyday clinical practice and can assist clinicians in the early diagnosis of this malignant tumor.
References
1.
Schiffner R, Schiffner-Rohe J, Vogt T, Landthaler M, Wlotzke U, Cognetta AB, et al. Improvement of early recognition of lentigo maligna using dermatoscopy. Journal of the American Academy of Dermatology. 2000;42(1):25–32.
2.
Lallas A, Tschandl P, Kyrgidis A, Stolz W, Rabinovitz H, Cameron A, et al. Dermoscopic clues to differentiate facial lentigo maligna from pigmented actinic keratosis. British Journal of Dermatology. 2016;174(5):1079–85.
3.
Higgins HW, Cho E, Weinstock MA, Li TY, Qureshi A, Li WQ. Gender differences, UV exposure and risk of lentigo maligna in a nationwide healthcare population cohort study. Journal of the European Academy of Dermatology and Venereology. 2019;33(7):1268–71.
4.
Matas‐Nadal C, Malvehy J, Ferreres JR, Boada A, Bodet D, Segura S, et al. Increasing incidence of lentigo maligna and lentigo maligna melanoma in Catalonia. International Journal of Dermatology. 2019;58(5):577–81.
5.
Aitken JF, Youlden DR, Baade PD, Soyer HP, Green AC, Smithers BM. Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995–2014. International Journal of Cancer. 2018;142(8):1528–35.
6.
Guitera P, Collgros H, Madronio CM, Goumas C, Mann GJ, Watts CG, et al. The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population‐based data on diagnosis and management. Australasian Journal of Dermatology. 2019;60(2):118–25.
7.
Tiodorovic-Zivkovic D, Argenziano G, Lallas A, Thomas L, Ignjatovic A, Rabinovitz H, et al. Age, gender, and topography influence the clinical and dermoscopic appearance of lentigo maligna. Journal of the American Academy of Dermatology. 2015;72(5):801–8.
8.
Peris K, Maiorino A, Di Stefani A, Longo C, Piana S, Argenziano G. Brown globules in lentigo maligna (LM): A useful dermoscopic clue. Journal of the American Academy of Dermatology. 2016;75(2):429–30.
9.
Tiodorovic-Zivkovic D, Zalaudek I, Lallas A, Stratigos AJ, Piana S, Argenziano G. The importance of gray color as a dermoscopic clue in facial pigmented lesion evaluation: a case report. Dermatology Practical & Conceptual. :37–9.
10.
Pralong P, Bathelier E, Dalle S, Poulalhon N, Debarbieux S, Thomas L. Dermoscopy of lentigo maligna melanoma: report of 125 cases. British Journal of Dermatology. 2012;167(2):280–7.
11.
WH C, MC M. Lentigo maligna and lentigo-maligna melanoma. Am J Pathol. 1969;55(1):39–67.
Durnick A, Stolz W, Landthaler M, Vogt T. Lentigo Maligna and Lentigo Maligna Melanoma in Young Adults. Dermatologic Surgery. 2004;30(5):813–6.
14.
Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing Incidence of Lentigo Maligna Melanoma Subtypes: Northern California and National Trends 1990–2000. Journal of Investigative Dermatology. 2005;125(4):685–91.
15.
Higgins HW, Lee KC, Galan A, Leffell DJ. Melanoma in situ. Journal of the American Academy of Dermatology. 2015;73(2):181–90.
16.
TANNOUS Z, LERNER L, DUNCAN L, MIHMJR M, FLOTTE T. Progression to invasive melanoma frommalignant melanoma in situ, lentigo maligna type. Human Pathology. 2000;31(6):705–8.
17.
Flotte TJ, Mihm MC. Lentigo maligna and malignant melanoma in situ, lentigo maligna type. Human Pathology. 1999;30(5):533–6.
18.
Becker SW. Dermatological investigations of melanin pigmentation. In: The Biology of Melanoma. 1948. p. 82–125.
19.
Hutchinson J. Senile freckles. Arch Surg. 1882;3:319–22.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
